首页> 外文期刊>Internal medicine. >Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.
【24h】

Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy.

机译:他克莫司的抢救疗法用于合并白细胞减少症和大剂量皮质类固醇疗法难以治疗的严重溃疡性结肠炎患者。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A19-year-old man complaining of severe diarrhea and hematochezia was admitted to our hospital. Endoscopic findings and laboratory data revealed that he had ulcerative colitis (UC). Despite combination therapy with high-dose corticosteroids and intensive granulocytapheresis, his condition did not improve. Therefore, we initiated tacrolimus therapy. Intravenous administration of tacrolimus with a trough level of 10 to 15 ng/ml relieved his abdominal symptoms within 1 week. The patient experienced no UC relapse 1 year after treatment with oral tacrolimus. Tacrolimus is a promising therapy for patients with UC refractory to the combination of high-dose corticosteroids and leukocytapheresis.
机译:一名主诉严重腹泻和便血的19岁男子入院。内窥镜检查结果和实验室数据显示他患有溃疡性结肠炎(UC)。尽管联合使用大剂量皮质类固醇和密集的颗粒运动疗法,他的病情并没有改善。因此,我们开始了他克莫司治疗。他克莫司的静脉内低谷水平为10至15 ng / ml,在1周内缓解了腹部症状。口服他克莫司治疗1年后,患者未见UC复发。他克莫司是大剂量皮质类固醇和白细胞穿刺术联合治疗的难治性UC患者的有前途的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号